The global diabetic footwear market size is expected to reach USD 9.65 billion by 2025, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 7.6% during the forecast period. Rising importance of specialty footwear which improve the lower body posture and protect the feet from fungal infection is expected to remain a favorable factor. Furthermore, rising concerns over adverse effects associated with obesity are expected to promote the use of diabetic footwear as a preventive measure.

Shoes are expected to generate a revenue of USD 3.31 billion by 2025. The segment is expected to lead the market in light of its increased utility among office-going population. Furthermore, fluctuating diet patterns and hectic lifestyle among middle class population in emerging economies including China and India is expected to encourage consumers to use diabetic shoes as a regular footwear option.

To request a sample copy or view summary of this report, click the link below: 
https://www.grandviewresearch.com/industry-analysis/diabetic-footwear-market